维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="HENG DY"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Factors Determining Diagnostic Yield of Endoscopic Ultrasound Guided Fine-Needle Aspiration for Pancreatic Cystic Lesions: A Multicentre Asian Study显示文摘	Lee Guan Lim Sandeep Lakhtakia Tiing Leong Ang Charles K. F. Vu Frederick Dy Vui Heng Chong Christopher J. L. Khor Wee Chian Lim Bhavesh Kishor Doshi Shyam Varadarajulu Kenjiro Yasuda Jennie Y. Y. Wong Yiong Huak Chan Min En Nga Khek Yu Ho	2013	Digestive Diseases and Sciences2013，，6：	2
2	The use of prognostic factors inmetastatic renal cell carcinoma 显示文摘	Li H Samawi H Heng DY	2015	Urol Oncol2015，33，：	1
3	Metastatic sarcoma-toid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy显示文摘	Golshayan AR George S Heng DY	2009	J Clin Oncol2009，27，2：	1
4	Sunitinib in the treatment of advanced solid tumors显示文摘	Imbulgoda A Heng DY Kollmannsberger C	2014	Recent Results Cancer Res2014，201，6：	1
5	Anti-angiogenic targets in the treatment of advanced renal cell carcinoma显示文摘	Heng DY Bukowski RM	2008	Curr Cancer Drug Targets2008，8，8：	1
6	Primary anti- vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and sub- sequent therapy显示文摘	Heng DY Mackenzie MJ Vaishampayan U'N	2012	Ann Oncol2012，23，6：	1
7	Prognostic factors for overall survival in patients withm metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents:results from a large,multicenter study显示文摘	Heng DY Xie W Regan MM	2009	J Clin Oncol2009，27，34：	1
8	Prednisone monotherapy in asymptomatic hormone refractory prostate cancer 显示文摘	Heng DY Chi KN	2006	Can J Urol2006，13，6：	1
9	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents:results from a large,multicenter Study显示文摘	Heng DY Xie W Regan MM	2009	J Clin Oncol2009，27，34：	1
10	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth 1actor-targeted agents : results from a large, multicenter study 显示文摘	Heng DY Xie W Regan MM	2009	J Clin Oncol2009，27，34：	1
11	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy显示文摘	Golshayan AR George S Heng DY	2009	J Clin Oncol2009，27，2：	1
12	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy 显示文摘	Golshayan AR George S Heng DY	2009	J Clin Oncol2009，27，：	1
13	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy显示文摘	Golshayan AR George S Heng DY	2009	J Clin Oncol2009，27，2：	1
14	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents:results from a large,multicenter study显示文摘	Heng DY Xie W Regan MM	2009	J Clin Oncol2009，27，34：	1
15	Metastatic sarcomatoid renal cell carcinoma treated with vascular endothelial growth factortargeted therapy显示文摘	Golshayan AR George S Heng DY		0，，01：	1
16	External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model:a population-based study显示文摘	Heng DY Xie WL Regan MM	2013	Lancet Oncol2013，14，2：	1
17	Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor-targeted agents:Results from a large,multicenter study显示文摘	Heng DY Xie W Regan MM Warren MA	2009	J Clin Oncol2009，27，34：	1
18	Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium显示文摘	HENG DY WELLS JC RINI BI	2014	Eur Urol2014，66，4：	1
19	Comparative effectiveness of second-line targeted therapies for metastatic renal cell carcinoma: a systematic review and Meta-analysis of real-world observational studies显示文摘	HENG DY SIGNOROVITCH J SWALLOW E	2014	PLoS One2014，9，11：	1
20	Stereotactic spine radiosur- gery (SRS) for pain and tumor control in patients with spinal me- tastases from renal cell carcinoma: a prospective study显示文摘	Angelov L Chao S Heng DY	2008	Int J of Radiat Oncol Biol Phys2008，72，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示